Herald Sun | Hepatitis C breakthrough drugs cost taxpayers $1bn in four months The Australian No sooner had breakthrough hepatitis C drugs been placed on the Pharmaceutical Benefits Scheme than they topped the list of the most expensive medicines for taxpayers to subsidise. After a 2015 recommendation from an expert advisory committee, the ... Use keywords to search content on this website |
Hepatitis C breakthrough drugs cost taxpayers $1bn in four months – The Australian
ByGoogle News
Dec 5, 2016